Jean Duvall

Jean Marie Duvall is the founder of ReproNovo SA, founded in 2021, holding the title Chief Executive Officer & Director.
Ms. Duvall was the founder of Trizell Holding SA, founded in 2014, holding the title Director & Chairman-Cell & Gene Therapy.
Ms. Duvall was the founder of Amzell BV, founded in 2016, holding the title Director.
Ms. Duvall is also the founder of Cell & Gene Therapy..
Ms. Duvall is currently Senior Independent Non-Executive Director at Ondine Biomedical, Inc. since 2021.
Ms. Duvall is currently Director, Executive VP & Group General Counsel at Ferring International Center SA since 2006.
Ms. Duvall is currently Non-Executive Director at Coiled Therapeutics Plc since 2022.
Former positions include Co-Chairman at FerGene, Inc., Director & Executive Vice President at Ferring Pharmaceuticals, Inc., Director at CPSI Holdings Ltd., Director at Ferring Research Ltd., Director at Ferring Laboratories Ltd., Director at Ferring Ventures Ltd., Director at CPSI Scotland Ltd., Director at FinVector Oy, Director at Kuopio Center For Gene & Cell Therapy Kct oy, Director at Gliotherapy Ltd., Director at International School of Lausanne, Director at Ferring Properties SA, Director at Ferring Pharmaceuticals SA from 2006 to 2020, and General Counsel at Elan Corp.
Plc from 2003 to 2005.
Education includes undergraduate studies at Case Western Reserve University and graduate studies at The Ohio State University.